Amniotic fluid 17-hydroxyprogesterone in early pregnancy

Area of Science:

• Biochemistry
• Prenatal Diagnostics
• Endocrinology

Background:

• Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a genetic disorder affecting fetal adrenal function.
• Early diagnosis is crucial for timely management and to prevent adverse outcomes.
• Amniotic fluid (AF) analysis is a potential method for prenatal diagnosis.

Purpose of the Study:

• To measure 17-hydroxyprogesterone (17-OH-P) levels in amniotic fluid during early gestation.
• To determine the feasibility of early prenatal diagnosis for CAH.
• To compare early gestation AF 17-OH-P levels with those from later stages.

Main Methods:

• Measurement of 17-hydroxyprogesterone (17-OH-P) in 125 amniotic fluid samples.
• Analysis of samples from early amniocenteses (gestational age not explicitly stated but implied to be from the first trimester).
• Comparison of early gestation AF 17-OH-P levels with previously published data from 16-22 weeks of gestation.

Main Results:

• AF 17-OH-P levels showed a slight but significant increase between 11 and 15 weeks of gestation, peaking at 14 weeks.
• No significant difference in AF 17-OH-P levels was observed between male and female fetuses.
• Overall AF 17-OH-P concentrations across gestational ages 12-22 weeks were statistically insignificant.

Conclusions:

• Biochemical prenatal diagnosis of CAH due to 21-hydroxylase deficiency can be performed as early as the end of the first trimester.
• This early diagnostic capability facilitates early fetal treatment control.
• The findings support the use of AF 17-OH-P for early prenatal diagnosis and management of CAH.